Litcius/Paper detail

Mitochondrial dysfunction in cellular senescence: a bridge to neurodegenerative disease

Adam Hruby, Ryo Higuchi‐Sanabria

2025npj Aging14 citationsDOIOpen Access PDF

Abstract

Senescent cells, characterized by a state of irreversible proliferative arrest and inflammatory profile, have emerged as drivers of age-related decline. Growing evidence suggests that alterations in mitochondrial function and morphology play a key role in the induction and maintenance of senescence, as well as in promotion of the proinflammatory senescence-associated secretory phenotype (SASP). In this review, we seek to survey the relationship between mitochondrial dysfunction and senescence, focusing on the consequences of changes in oxidative phosphorylation efficiency, calcium handling, mitochondrial metabolites, mitochondrial dynamics and quality control, and release of damage-associated molecular patterns. We first describe these changes before illustrating the pathways and mechanisms through which mitochondrial dysfunction results in cell cycle arrest and the SASP. Lastly, we showcase evidence relating cellular senescence to neurodegenerative disease and propose that mitochondrial dysfunction may act as a bridge between the two.

Topics & Concepts

MitochondrionCell biologyBiologyProinflammatory cytokineDiseasePhenotypeOxidative phosphorylationFunction (biology)NeuroscienceSenescenceOxidative stressOxidative damageContext (archaeology)NeurodegenerationPhosphorylationBridge (graph theory)Mitochondrial DNACitric acid cycleMechanism (biology)Programmed cell deathmitochondrial fusionPINK1MediatorAutophagyCellCalcium signalingReactive oxygen speciesCalciumBioinformaticsInflammationApoptosisSignal transductionClinical phenotypeTelomeres, Telomerase, and SenescenceMitochondrial Function and PathologyGenetics, Aging, and Longevity in Model Organisms
Mitochondrial dysfunction in cellular senescence: a bridge to neurodegenerative disease | Litcius